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Abstract: Recovery from injuries to the central nervous system, including 
spinal cord injury, is constrained in part by the intrinsically low ability of many 
CNS neurons to mount an effective regenerative growth response. To improve 
outcomes, it is essential to understand and ultimately reverse these neuron-
intrinsic constraints. Genetic manipulation of key transcription factors (TFs), 
which act to orchestrate production of multiple regeneration-associated 
genes, has emerged as a promising strategy. It is likely that no single TF will 
be sufficient to fully restore neuron-intrinsic growth potential, and that 
multiple, functionally interacting factors will be needed. An extensive 
literature, mostly from non-neural cell types, has identified potential 
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mechanisms by which TFs can functionally synergize. Here we examine four 
potential mechanisms of TF/TF interaction; physical interaction, 
transcriptional cross-regulation, signaling-based cross regulation, and co-
occupancy of regulatory DNA. For each mechanism, we consider how existing 
knowledge can be used to guide the discovery and effective use of TF 
combinations in the context of regenerative neuroscience. This mechanistic 
insight into TF interactions is needed to accelerate the design of effective TF-
based interventions to relieve neuron-intrinsic constraints to regeneration and 
to foster recovery from CNS injury. 
 
Keywords: Transcription factor, Axon regeneration, Co-occupancy, 
Combination, Network, Spinal cord injury 
1. Introduction 
Coaxing robust, long distance regeneration from injured neurons 
remains a major unmet challenge in the treatment of spinal cord 
injury. Although extrinsic barriers to axon regeneration contribute, 
cell-intrinsic mechanisms within injured CNS neurons also limit axon 
growth.10 and 17 Axon extension requires a profound change in cellular 
state within injured neurons. Prior to axotomy, neurons are tasked 
with maintaining intracellular communication and structural 
homeostasis in far-flung processes; after axotomy, regeneration 
demands the production, transport, and regulated assembly of 
enormous amounts of cytoskeletal and membranous material. The 
sheer number of genes that must be up- or down-regulated to 
reinitiate axon extension presents a major challenge to targeting the 
neuron-intrinsic growth state.10,47 One possible solution is that 
underlying transcription factors (TFs) might be manipulated in injured 
neurons, perhaps acting as simple levers to alter the expression of 
large numbers of downstream regeneration-associated genes (RAGs). 
A growing number of TFs have been functionally linked to axon growth 
in a variety of cell types (Table 1). Indeed, manipulation of TFs 
including KLFs, SOX11, and STAT3 has enhanced regenerative axon 
growth after spinal injury.11,37,85 On the other hand, the number and 
regenerative speed of treated axons likely remains well below the 
threshold for functional recovery. 
Table 1. Summary of regeneration associated TFs (RAG TFs) shown to 
regulate axon growth in vivo. 
Regeneration 
associated TFs 
Model of regeneration References 
ATF3 Sciatic nerve crush Seijjfers et al67 
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Regeneration 
associated TFs 
Model of regeneration References 
cJUN Facical nerve transection Raivich et al.65 
 
Sciatic nerve crush Saijilafu et al.66 
CREB Conditioning lesion Gao et al.27 
KLF7 Pyramidotomy and cervical 
SCI 
Blackmore et al.11 
HIF1alpha Sciatic nerve crush Cho et al.16 
MYC Optic nerve injury Belin et al.6 
MASH1 Thoracic SCI Williams et al.87 
p53 Facial nerve axotomy Tedeschi et al.78 
SMAD1 Thoracic SCI Parikh et al.62 
SOX11 Saphenous nerve crush Jankowski et al.35 
 
Pyramidotomy and cervical 
SCI 
Wang et al.85 
KLF4 Optic nerve injury Moore et al.56 
STAT3 Saphenous nerve crush Bareyre et al.5 
 
Dorsal column transection- 
DRGs 
 
 
Unilateral pyramidotomy Lang et al.,201342 
 
Optic nerve injury Smith et al., Luo et al.49,69 
One explanation for this limited response may be that no single 
TF is sufficient to drive a full regenerative program. Instead, groups of 
functionally interacting factors are likely needed, similar to the 
situation in induced pluripotency.74 Indeed, recent work in the optic 
system makes it plain that combinatorial gene manipulations are most 
effective in producing axon regeneration.6,49,73 Although plausible in 
principle, this combinatorial perspective brings with it the challenge of 
identifying optimal sets of TFs.77,79 With well over one thousand TFs in 
the genome and at least a dozen already linked to regenerative axon 
growth in vivo ( Table 1), the number of possible combinations is 
daunting. 
Here we argue that optimal selection of pro-regenerative TF 
combinations requires careful consideration of the underlying 
mechanisms of interaction. Fundamentally, the specifics of the various 
molecular interactions between TFs have profound implications for the 
discovery and eventual use of TF combinations to improve 
regenerative axon growth. To illustrate this, we briefly consider four 
general mechanisms by which TFs can functionally interact. For the 
sake of clarity, we frame the discussion around two-way interactions 
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between factors, with the understanding that this basic framework 
must eventually be scaled to accommodate multi-factor networks. For 
each mechanism we 1) examine instances in which the mechanism has 
been demonstrated in TFs linked to axon growth 2) examine how the 
mechanism informs improved discovery of TF/TF interactions and 3) 
consider the implications of the mechanism for optimal co-
manipulations. This consideration of the details of TF/TF interactions is 
critical to accelerate the discovery of optimal TF mixtures and improve 
the efficacy of combinatorial manipulations. 
2. Physical interaction 
TFs can directly bind to one another and reciprocally influence 
activity (Fig. 1). Indeed, some families of TFs, notably bZIP, bHLH, 
and STATs, are obligate dimers; the ability to bind DNA is conferred by 
the presence of two subunits [reviewed in2]. Obligate dimers form both 
homo- and heterodimers, commonly with related family members. 
Importantly, transcriptional activity can be increased or suppressed 
depending on the specific partnerships formed, creating a system for 
graded control of transcription. A highly relevant example involves the 
bZIP AP1 factors, JUN and ATF3. Previous work indicates that JUN 
homodimers drive moderate activation of target genes and JUN-ATF3 
heterodimers drive strong activation, whereas ATF3 homodimers can 
act to repress transcription.4 JUN and ATF3 have been individually 
linked to axon regeneration,65,67 and single overexpression of each has 
been attempted to enhance regenerative outcomes. Intriguingly, it 
was recently shown that forced co-expression of both factors is more 
effective in promoting axon growth in sensory neurons than either 
alone.13 These data raise the possibility that the synergistic effects of 
co-expressed JUN and ATF3 in sensory axon growth might be 
explained by direct binding, although this possibility has yet to be 
directly tested. 
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Fig. 1. Transcription factors functionally interact through distinct mechanisms. The 
left-hand column illustrates four potential mechanisms of TF/TF interaction. The 
middle column lists experimental techniques and bioinformatics resources that can be 
used to identify each mechanism. The right-hand column lists the implications of each 
mechanism for optimizing the use of multiple TFs for maximal effect. 
In addition to obligate dimers, physical interaction between TFs 
is also common across TF classes, and between TFs that normally 
function as individual subunits (e.g. zinc finger TFs). In one highly 
relevant example from optic nerve regeneration, KLF4, which acts to 
inhibit axon growth in this system, physically associates with and 
inhibits pro-regenerative STAT3 (Qin et al.). In addition, a wide range 
of physical interactions between RAG TFs, shown mostly in non-neural 
cell types, are summarized in Fig. 2 (references provided as hyperlinks 
in Supplementary Table S1). Notably, p53 (TP53) can bind seven of 
the twelve RAG TFs (STAT3, KLF6, MYC, ATF3, CREB, HIF1A, SMAD1), 
and STAT3 binds five (KLF4, ATF3, SMAD1, p53, HIF1A). In summary, 
although data in neurons remain sparse, evidence from non-neural cell 
types strongly supports the possibility that TFs implicated in 
regeneration may influence one another’s activity in part through 
direct physical association. 
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Fig. 2. Existing data establishes functional interactions between regeneration-
associated transcription factors. (A) Identified interactions between RAG-TFs are 
categorized by mechanism, indicated by color, and by numbers to indicate the source 
reference, below. References are provided as hyperlinks in Supplementary Table S1. 
(B–E) Existing databases were used to identify interactions between RAG-TFs. 
STRINGdB identified physical binding between TFs (B), TRRUST identified 
transcriptional hierarchies (C), TRANSPATH and IPA identified cross-regulation through 
signaling intermediates (D), and combined IPA, literature mining, and ENCODE data 
identified factors that co-occupy regulatory DNA regions (E). 
2.1. Implications for discovery 
Physical binding between TFs is perhaps the most 
straightforward type of interaction to identify. Datasets and network 
tools that include physical interactions, although built largely from 
non-neural cell types,14,24,31,44,60 are readily available and are already 
being used to help prioritize TFs of interest in the context of 
regeneration research.13,77,79 A driving assumption of this approach is 
that TFs with large numbers of known interactions act as hub proteins 
and are thus high priority targets for functional intervention. Although 
certainly valid, an important caveat to this assumption is that the 
number of known physical interactions for each TF is highly influenced 
by the interest that TF has previously received, mostly in non-neural 
cell types. For example, a Pubmed search for p53 identifies >80,000 
manuscripts, STAT3 identifies >15000, and a search for KLF6 yields 
less than 400. Thus it is perhaps unsurprising that the number of 
known interactions with other RAG TFs is higher for p53 and STAT3. 
When extrapolating available network data to prioritize TFs for 
regenerative axon growth, care must to taken to avoid a self-
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reinforcing interest in well-studied factors, at the expense of TFs that 
may be less well studied but functionally important. 
Unbiased methods are available to discover physical interactions 
between TFs. For example, novel TF binding partners can be identified 
by proteomic analysis involving immunoprecipitation with mass 
spectrometry.28 In a complementary approach, the spatial distribution 
of TF binding in the genome can be used to predict possible physical 
interactions.82 First, chromatin immunoprecipitation and high 
throughput sequencing (ChIP-Seq) can be used to determine genome-
wide locations of binding by TFs of interest. Then, bioinformatic tools 
are used to scan adjacent sequences for recognition motifs of potential 
partner TFs, with particular attention paid to promoter and enhancer 
regions for genes of interest, in this case, regeneration-associated 
genes. If two TFs bind one another and then additionally bind DNA, 
this can be detected in TF binding sites in very close proximity. 
Software packages are now available for this approach.50 In this way, 
starting from a TF that is known to promote regeneration, it would be 
possible to identify other TFs that commonly bind, which would act to 
prioritize candidate TFs in subsequent co-expression functional tests. 
2.2. Implications for functional intervention 
The prevalence of TF/TF interactions at the protein level raises 
important considerations of stoichiometry. The importance of TF 
stoichiometry is well established for efficient cellular reprogramming,58 
and it is likely that efforts to improve axon growth by delivery of 
multiple TFs will similarly depend on optimal ratios of co-expression. 
For example, the observation that JUN-ATF3 heterodimers have been 
shown to drive strong transcriptional activation, while ATF3 
homodimers act to repress transcription, raises the possibility that the 
phenotypic effects of forced co-expression will vary according to the 
relative levels. An excess of ATF3 over JUN could facilitate homodimer 
formation, tilting the balance toward repression. This issue is 
significant because in most standard methods of gene delivery (e.g. 
plasmid transfection or viral delivery) the level of protein production is 
quite variable and difficult to control. In this way, experimental tests of 
forced co-expression could miss possible ratio-specific synergies. It is 
even possible that uncontrolled stoichiometry might help explain 
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differences in the reported efficacy of JUN/ATF3 co-expression in 
promoting sensory axon growth.13,22 
One possible solution to achieve more controlled stoichiometry 
is polycistronic expression of multiple factors from the same construct. 
If approximately equivalent levels of two TFs is desired, a 2A-peptide 
approach can be utilized.11,75 In this way, although individual cells will 
still receive varying levels of TFs, the ratio of the two will be much 
more consistent. Alternatively, a dual promoter design in which each 
TF is under the control of a different promoter, could enable skewed 
ratios by selecting promoters with differing levels of activity in the cell 
type of interest.48 In addition, when the optimal ratio is unknown, it 
should also be possible to take advantage of inducible promoters to 
systematically vary the production of exogenously expressed TFs. For 
example, it was recently found using a Tet-on plasmid and varying 
levels of doxycyclin that the growth-promoting effects of HIF1A are 
concentration dependent.16 This approach could be extended to dual-
overexpression experiments to systematically test a range of 
expression ratios. Finally, in situations in which particular TF–TF 
binding is desired, so-called “tethered” constructs can be constructed 
in which two TFs are produced as a single protein, with the two units 
linked by a flexible amino acid tether. This strategy has been used to 
force interactions that favor motorneuron development,26 and notably, 
has been used to force Jun/ATF3 cooperativity.4 Thus when 
contemplating co-expression of pro-regenerative TFs that can 
potentially physically interact, similar strategies to control 
stoichiometry and association should be considered. 
An additional complication is the potential for extra-nuclear 
activities by TFs. One prominent example is STAT3, which in addition 
to the nucleus, is also known to localize to the cytoplasm and 
mitochondria in CNS neurons.49,68,92 In early embryonic spinal 
motorneurons, growth-promoting effects of cytoplasmic STAT3 are 
largely independent of transcription,68 driven instead by axonal STAT3 
stabilizing microtubules. In adult retinal ganglion cells, viral treatment 
of mitochondrial STAT3 along with constitutively-active STAT3 was 
more effective in promoting optic nerve regeneration than either 
treatment alone.49 Therefore, it is important to consider potential non-
nuclear localization of RAG TFs when overexpressed, which could 
variably impact axon regeneration. One approach to do so involves 
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conventional cloning techniques and the overexpression of DNA-
binding mutants or the addition of nuclear localization signals (NLS) or 
Nuclear export signals (NES).49 Alternatively, recent advances in 
synthetic biology allow for precise and reversible control of nuclear 
translocation of proteins in response to light-stimulation, a potentially 
powerful approach to distinguish nuclear from extra-nuclear functions 
of TF proteins.86 
3. Transcriptional cross-regulation 
Transcription factors can potentially elevate or suppress the 
transcription of “downstream” TFs by directly targeting relevant 
promoter or enhancer regions (Fig. 1). In this model, an early wave of 
TFs important for axon growth could potentially act to initiate 
secondary cascades of additional pro-regenerative TFs. Alternatively, 
pro-regenerative TFs might also trigger homeostatic mechanisms in 
which they activate expression of TFs that then act to limit 
regeneration. 
The focus here is on direct transcriptional regulation between 
TFs, which requires stringent experimental evidence. A continuum of 
experimental approaches provide varying degrees of certainty for 
direct transcriptional regulation. Correlative experiments, in which 
forced expression or knockdown of one TF leads to a change in 
expression of a second, hint at transcriptional cross-regulation but 
can’t distinguish direct transcriptional activation from indirect 
consequences of downstream effector proteins. For instance, in 
sensory neurons responding to peripheral injury, knockdown of SOX11 
leads to reduced ATF3 expression, and in oligodendrocyte precursor 
cells, activation of STAT3 leads to elevated transcription of KLF6.35,41 
These data hint at transcriptional cross-regulation, but a mechanism of 
direct transcriptional regulation was not established. 
To make a strong case for direct transcriptional regulation, two 
additional types of data are needed. First is evidence for binding of a 
TF to the regulatory region(s) of the putative target TF. This evidence 
can be purely predictive, such as scanning promoter/enhancer 
sequences for canonical TF binding motifs, can involve in vitro binding 
(e.g. gel shift mobility assays), or can be performed in vivo (chromatin 
immunoprecipitation- ChIP). ChIP provides the strongest evidence for 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience Letters, (December 2016). DOI. This article is © Elsevier and permission has been granted for this version to 
appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further copied/distributed 
or hosted elsewhere without the express permission from Elsevier. 
10 
 
binding, although it must be kept in mind that binding of TFs to 
specific genomic loci is highly cell-type specific.28 Second, after binding 
is established, functional evidence for transcriptional regulation by TF 
binding (e.g. luciferase assays) is also needed. In general, strong 
evidence for the ability of RAG TFs to bind and regulate other TFs is 
scarce in neurons, but can be found in other cell types (Fig. 2 and 
Supplementary Table S1). Intriguingly, STAT3 transcriptionally 
regulates 4 other RAG TFs, KLF6, KLF4, MYC, and HIF1A (Fig. 2C). 
Three of these STAT3 targets in turn transcriptionally regulate 
additional downstream RAG TFs, hinting at a potential transcriptional 
hierarchy among RAG TFs. In addition, p53 binds the ATF3 promoter 
and activates transcription, while ATF3 binds and represses the p53 
promoter, suggesting a loop of feedback inhibition.38,90 These data hint 
that similar transcriptional relationships between RAG TFs may 
regulate axon growth. 
3.1. Implications for discovery 
In principle, transcriptional relationships between RAG TFs 
should be relatively straightforward to identify. Initial analyses would 
involve transcriptional profiling of neurons after forced expression or 
knockdown of one RAG TF, in order to determine whether the 
expression of other RAG TFs changes in response. Follow-up motif 
analysis of promoter/enhancer regions, ChIP, and expression assays 
(e.g. luciferase) could then rule in or out direct transcriptional 
relationships. Indeed, this discovery workflow has been applied to 
single target genes in regenerating neurons,31,78 and genome-wide in a 
variety of non-neural cells (See Fig. 2, Supplementary Table S1, 
and41). These transcriptional relationships are described in searchable 
databases including IPA and TRRUST31,79 and raise the possibility that 
similar relationships may exist in neurons. In summary, genome-wide 
discovery efforts focused on neurons and targeted verification of 
predicted transcriptional relationships offer a rapid way to expand 
knowledge of TF networks in regenerative neuroscience. 
3.2. Implications for functional intervention 
Greater clarity regarding transcriptional relationships between 
RAG TFs would be quite useful in two ways. First, clarifying TF 
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cascades and hierarchical relationships in regeneration would assist in 
selecting top-level TFs that can drive secondary expression of 
additional TFs for maximal effect. In one simple example, if the 
observation that STAT3 activation leads to elevated KLF6 expression 
(above) holds true in a neuronal context, this information would 
prioritize STAT3 interventions for combinatorial gain. As hierarchical 
cascades are clarified, perhaps a relatively small set of core TFs could 
be identified whose expression might achieve widespread activation of 
a larger cohort of needed TFs. Second, knowledge of transcriptional 
hierarchies might help avoid unintended and counter-productive 
consequences of TF interventions. Indeed, it is clear that pro-
regenerative TFs can engage homeostatic mechanisms that ultimately 
dampen their pro-regenerative activities. One well-studied example 
involves STAT3, which upregulates the expression of SOCS3, which in 
turn represses STAT3 activity. Genetic deletion of SOCS3 is now a 
well-established means to enhance STAT3 activity.73 By analogy, it is 
conceivable that pro-regenerative TFs engage homeostatic 
transcriptional mechanisms that act to repress expression of other 
RAG TFs; such a relationship is hinted at by the upregulation of KLF4, 
a growth-repressive TF, by STAT3.30 Identifying such homeostatic 
circuits, and devising ways to circumvent them, may amplify net pro-
regenerative effects. In summary, increased information regarding 
transcriptional relationships between pro-regenerative factors will 
facilitate combinatorial strategies that are maximally efficient by 
favoring top-level factors, and which may help avoid unintended 
(negative feedback) consequences of TF intervention. 
4. Cross-activation through downstream effectors 
The activity of TFs is controlled not only by abundance, but also 
through a variety of post-translational modifications and the 
availability of co-factors. Thus, in addition to the direct transcriptional 
relationships considered above, TFs can influence one another’s 
activity indirectly by altering the expression of upstream regulators of 
a second TF (Fig. 1C). For example, KLF factors do not appear to alter 
STAT3 expression, but may influence STAT3 activity through upstream 
regulators. Specifically, in oligodendrocyte precursor cells, KLF6 binds 
and activates the promoter region of gp130, a cytokine receptor, 
which in turn elevates JAK signaling and STAT3 activation.41 Similarly, 
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in neural stem cells, KLF4 transcriptionally activates cytokine receptors 
and JAK3, leading to STAT3 phosphorylation and activation.77 In 
adipocytes, HIF1A also affects STAT3 activity through transcriptional 
activation of SOCS3, an inhibitor of STAT3 signaling.36 In 
mesenchymal stem cells, SOX11 transcriptionally increases expression 
of BMP receptors, which leads to activation of SMAD1.68 In hepatic 
tumors, KLF6 transcriptionally represses MDM2, a major inhibitor of 
p53, and thus acts to increase p53 activity.76 Additional examples can 
be found in Fig. 2 and Supplementary Table S1, illustrating widespread 
occurrence of TF cross regulation through signaling mechanisms. 
4.1. Implications for discovery 
For RAG TFs with regulatory PTMs that are well established and 
readily detectable (e.g. effective phospho-specific antibodies), 
signaling cross-talk from other TFs is relatively easy to detect. For 
example, the activity of STAT3, SMAD1, and JUN are all known to be 
controlled in part by phosphorylation, and phospho-specific antibodies 
exist for all three. Thus, forced expression or knockdown of a battery 
of RAG TFs could be followed by assessment of changes in 
phosphorylation state. Similarly, when upstream regulators of TFs are 
known (e.g. MDM2 as a well-established repressor of p53 activity, or 
SOCS3 as a STAT3 inhibitor), the abundance of these regulators can 
be readily monitored after manipulation of other TFs. The situation is 
much more challenging, however, for TFs such as SOX11 and KLFs. 
Although some information regarding KLF phosphorylation and 
acetylation is available, there remains a dearth of knowledge regarding 
upstream regulators of activity for these zinc finger factors.3,57 Thus for 
some factors, detection of TF–TF interactions via signaling cross-talk 
awaits more information regarding regulatory modifications and the 
development of PTM-specific antibodies. 
4.2. Implications for functional intervention 
Perhaps the most important implication of signaling-based 
cross-talk between TFs is the possibility that such cross-regulation 
might could be mimicked or blocked by pharmacological agents. That 
is, if functional synergy between two TFs results in part from the 
ability of one factor to activate another TF through signaling 
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intermediates, (e.g. JAKs or JNKs), then pharmacological activation of 
these intermediates may amplify the synergy. In addition, as 
discussed above regarding transcriptional relationships, pro-
regenerative TFs may engage homeostatic growth-suppressive 
signaling mechanisms. In that scenario, pharmacological inhibition of 
these pathways might increase net growth promotion. Finally, whether 
the goal is to amplify or dampen downstream signaling cascades that 
link TFs, an alternative to pharmacology is forced expression of mutant 
TFs that mimic or prevent the relevant modifications (e.g. phosphor-
mimic or −null mutants). As one example, if KLF6 leads to elevated 
STAT3, then perhaps this effect might be amplified by expression of 
constitutively active STAT3 mutations.49 Thus, increased understanding 
of signaling cascades affected by TF expression is important for 
regenerative neuroscience by guiding the rational development of TF 
modifications and potential combination with pharmacological agents. 
5. Co-occupancy of regulatory DNA 
Gene transcription is regulated by the binding of TFs to cis-
regulatory DNA sequences. These elements are often conceptually 
divided into short-range elements such as promoter regions, found 
within 1kB 5′ to transcriptional start sites, and long-range regulatory 
elements such as enhancer regions that can influence transcription 
from locations as far as 100 s of Kb in either the 5′ or 3′ direction. 
Although data from neurons remains limited, extensive ChIP-based 
profiling datasets have emerged for a range of TFs in a variety of cell 
types, creating an increasingly clear picture of genome-wide binding. 
For example, the ENCODE project has generated genome-wide ChIP-
Seq data for more than 100 TFs, complemented by genome-wide 
profiling of chromatin accessibility and epigenetic modifications. These 
integrated datasets allow powerful correlative analysis between TF 
binding location, chromatin status and accessibility, and expression at 
loci across the genome.83 A key insight to emerge from these datasets 
is that transcription is rarely predicted by the binding of any single 
factor, but rather reflects binding by multiple TFs to both promoter and 
enhancer elements. For example, in developing erythrocytes, co-
occupancy by three TFs, TAL1, GATA1, and SMAD1, proved to be a 
predictor of enhancer activity with a remarkable 80% accuracy; single 
binding by any one factor was much less predictive.20 Similarly, 
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genome-wide binding by more than 100 TFs, generated by the 
ENCODE project, was analyzed for co-occupancy by TFs. Interestingly, 
when considering genes whose expression is highly cell-type specific, 
the cells in which transcription selectively occurred were marked by 
binding of between 8 and 12 distinct factors to the promoter region, 
whereas non-expressing cell types showed binding by zero to three 
factors. Again, occupancy by multiple TFs, and no single TF, predicts 
expression.82 
A variety of mechanisms can explain additive or synergistic 
transcriptional effects of co-occupancy. One possibility is that two 
factors interact with different, widely separated regulatory regions. For 
example, one TF may bind a proximal promoter but confer minimal 
transcriptional activation until a second TF binds and activates a distal 
enhancer. Other mechanisms depend on co-occupancy of different TFs 
in close proximity on the same promoter or enhancer. Recruitment of 
multiple TFs may facilitate activation by leading to non-linear gains in 
nucleosome displacement,54,81 by enhancing the association of co-
activators such as p300 (transcriptional synergy),53 initiation of local 
DNA bending by TFs (eg HMG1) which may increase the affinity for 
other TFs.23,55 In all cases, the critical point is that co-occupancy 
models indicate that TFs can profoundly influence one another’s 
transcriptional output without necessarily engaging in direct binding or 
reciprocal regulation of abundance/activity (Fig. 1D). 
5.1. Implications for discovery 
Most fundamentally, the potential for functional interaction 
through co-occupancy means that in the search for functional 
combinations of TFs to promote axon growth, sole reliance on protein–
protein and transcriptional relationships may fail to detect important 
network members. Analysis of the spatial relation of TF binding sites 
provides an alternative means to uncover possible co-regulators. This 
strategy involves 1) genome-wide analysis of binding by TFs of 
interest in a relevant cell type and 2) scanning of nearby or 
functionally grouped sequences (e.g. disparate enhancers that 
regulate a common gene) for statistically over-represented binding 
motifs of other TFs. An illustrative example comes from the study of 
motorneuron development. Starting from previous observations that 
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an LHX1-ISL1 tethered construct promotes MN differentiation, Lee et 
al. performed ChIP-Seq analysis to identify several thousand binding 
sites in differentiating stem cells.43 Motif analysis revealed that 80% of 
these sites were in close proximity to predicted binding sites for 
STAT3, suggesting a previously unknown cooperative role. Indeed, 
follow-up experiments revealed an important functional requirement 
for STAT3 in recruitment of the LHX1-ISL1 construct and MN 
differentiation. The basic strategy of using genome-wide occupancy 
data to discover new members of TF regulatory networks has been 
employed with great effect in the study stem cell differentiation,59 
cancer biology,89 hematopoetic differentiation29 and more. In addition, 
an integrated analysis of TF ChIP-seq data from multiple cell types 
mapped a co-occupancy matrix for more than 100 TFs, including 7 
RAG TFs. These analyses reveal intriguing examples of co-occupancy 
by RAG TFs, including nearly 50% co-occupancy by STAT3 with both 
MYC and JUN (Fig. 2). 
What is needed to employ a similar strategy in regenerative 
neuroscience? First, and most fundamentally, the requisite ChIP-Seq 
datasets must be created. In comparison to other fields (above) 
regenerative neuroscience has made little progress in developing 
datasets of genome-wide binding by RAG TFs in relevant cell types 
(e.g. regenerating peripheral neurons or early developmental CNS 
neurons). TF binding patterns can change dramatically between cell 
types and even within a single cell type across development,7,25,28 
Nevertheless, ChIP-seq datasets are available for RAG TFs in the 
context of neural differentiation (SOX117) and in adult activity-
dependent plasticity (AP1 factor FOS,51). Data are also available from 
non-neural cell types for KLF6,41 STAT3,33 SMAD1, MYC, KLF4,15 JUN,46 
and ATF3.91 Thus, until neuron-specific datasets are developed, these 
data may serve as first-pass indicators of potential co-occupancy 
relationships for RAG TFs. 
Second, because the majority of TF binding sites occur at great 
distances from transcription start sites, an ongoing challenge in all 
fields is to identify which of these sites correspond to genuine cis-
regulatory (e.g. enhancer) regions. To date, no features of the primary 
DNA sequence have been identified that can reliably distinguish 
enhancers from non-regulatory regions. Instead, biochemical 
signatures specific to enhancers have been used. For instance, 
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enhancer regions tend to be nucleosome depleted, so one approach 
involves profiling chromatin accessibility genome-wide using DNAase-
seq,21 or the more recent ATAC-Seq.19 For a more targeted approach, 
presence of histone marks such as H3K4me132 or H3K27Ac,18 and 
binding by regulatory factors like p300,12,52,80 or even binding by 
specific TFs20 have been used to predict enhancer function across the 
genome, with varying success. Although a great majority of genome-
wide efforts to identify enhancer regions have been performed in non-
neuronal cell types, genome-wide sequencing for a battery of promoter 
and enhancer specific histone marks have been carried out on brain 
tissue derived from embryonic mice as part of the ENCODE project1 
(https://www.encodeproject.org) and on adult brain tissue as part of 
the Roadmap epigenomics project8 
(http://www.roadmapepigenomics.org). A major caveat to using these 
datasets is that the heterogeneous source material likely dilutes the 
signatures of specific cell types. In silico platforms exist to tackle this 
issue, in which binding profiles/expression profiles are tested against 
profiles from cell-type specific genes, to correlate which cell-type best 
represents the mixed-cell dataset.25,40 
Finally, once enhancer regions are identified, their tremendous 
distance from gene loci creates ambiguity regarding the gene(s) under 
regulation. Although the assumption is often made that the relevant 
enhancers are those located nearest to a gene of interest, this 
assumption is debatable.88 In summary, although progress in other 
fields illustrates the tremendous potential of co-occupancy analysis to 
reveal TF–TF interactions of importance to regenerative neuroscience, 
development of this approach must await basic information regarding 
the distribution of TF binding, enhancers active in neurons, and 
perhaps clearer mapping of enhancers to gene loci. 
5.2. Implications for therapy 
Strategies to select optimal combinations of TFs will be strongly 
influenced by the specific mechanisms through which co-occupying TFs 
influence transcription. At one extreme, TFs could be considered to 
make additive contributions to similar processes, either positively or 
negatively.63 For instance, each individual factor could be partially 
effective at displacing nucleosomes, adding or removing epigenetic 
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marks that favor activity, or recruiting a common set of activators or 
repressors. In this model, TFs are effectively functionally 
interchangeable, and the strategy for optimal manipulation is relatively 
straightforward. Once regulatory elements and their bound TFs are 
identified, this model would favor simultaneous expression of the 
maximal number of transcriptional activators and/or maximal 
knockdown of transcriptional repressors. 
A very different picture emerges when considering the likelihood 
that co-occupying TFs achieve functional synergy by regulating diverse 
and complementary aspects of transcriptional activation. That is, some 
TFs may primarily modify epigenetic marks, others may enhance 
accessibility through chromatin bending, and others may recruit 
specific co-factors. An important implication of this model is that 
priming of chromatin by one TF could be a pre-requisite for 
recruitment of others. Indeed, an emerging concept in stem cell 
biology is that some TFs act as so-called “pioneer factors” and play an 
essential role in accessing closed chromatin and remodeling it to allow 
subsequent binding by additional TFs.34,71,72 An interesting example 
comes from genome-wide profiling of chromatin accessibility and co-
occupancy of AP1 and Glucocorticoid receptor (GR). This study 
revealed that AP1 binding preceded GR binding, creating an accessible 
chromatin state around critical genomic loci, and was essential for 
subsequent GR binding and activity.9 
The first implication of this model is that when selecting TF 
combinations for maximal effect, what matters most is not the number 
of TFs but rather the diversity of mechanisms that can be engaged. 
The issue of chromatin accessibility is particularly important, as single 
or even sets of TFs that normally target important regulatory regions 
may be unable to do so without appropriate chromatin remodeling 
factors. Overall, careful consideration of TFs that confer 
complementary activities, and particular attention to including TFs that 
assist in targeted opening of chromatin, may be an effective strategy 
to select functional sets of TFs for axon growth. 
A second implication is that issues of timing and sequence must 
also be considered. It is clear that in some cases, complementary 
transcriptional mechanisms must be engaged in a strict order. For 
example, pioneer factors must precede other TFs in order to prepare 
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the chromatin landscape for subsequent binding, and significant delays 
can exist between the onset of pioneer expression and appropriate 
chromatin remodeling. Thus synergistic effects may not be evident 
from TF/pioneer co-expression in short-term assays. An additional 
challenge is that in some cases early-acting TFs must be silenced 
before later-acting factors can be effective. For example, Sox family 
members, including the RAG TF SOX11, must be up- and down-
regulated in strict sequence during early neural differentiation.7 First, 
SOX3 binds widely to the genome of neural progenitor cells and acts to 
alter epigenetic marks. As the progenitor cells differentiate into 
neurons, SOX3 is downregulated and SOX11, which drives early 
expression of neural-specific genes important for axon growth, is 
upregulated. Interestingly, although SOX3 promotes epigenetic 
remodeling that facilitates subsequent SOX11 activity, it also 
physically competes with SOX11 to occlude binding; downregulation of 
SOX3 is essential for subsequent SOX11 activity. In other words, SOX3 
and SOX11 cooperate to activate genes involved in axon growth, but 
in a manner that requires SOX3 expression to precede SOX11, and 
critically, to be transient. Thus prolonged co-expression of both 
factors, which is typical of many common gene delivery techniques, 
would not be optimal in this case. 
Recent advances offer unprecedented opportunities to answer 
questions regarding the role of timing and sequence in transcriptional 
output. For example, the GAVPO system, based on light-triggered 
dimerization of DNA-binding domains, allows tight control of both the 
timing and amount of transgene expression.84 In one relevant 
application, GAVPO was used to control Brn2 expression in embryonic 
stem cells, in order to query how timing and dose affect the regulatory 
network of pluripotency TFs.70 Alternatively, multiple groups have 
engineered DNA binding motifs and functional domains such that their 
association can be controlled optically.39,61,64 When delivered to cells 
these constructs enable tight temporal control of transcriptional 
activity, transcriptional repression, or targeted epigenetic 
modifications.39,45,61 Thus in principle, multiple TFs can be delivered to 
neurons, with the expression or function of one or more factors 
regulated by optical stimulation. In this way, by systematically varying 
optical stimulation while quantifying rates of axon growth, it should be 
possible to determine how the timing and duration of expression of 
specific members of multi-TF sets impacts cooperative function. 
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6. Conclusions and future prospects 
It is likely that multiple, interactive transcriptional programs 
must be engaged to restore full regenerative potential in CNS neurons. 
How to identify the optimal set of factors, and how to optimally deliver 
these factors once identified, are core questions. Progress in other 
fields provides a conceptual framework to classify TF interactions, and 
provides a roadmap for progress in regenerative neuroscience. 
Techniques are available to establish physical, transcriptional, 
signaling, and co-occupancy relationships between TFs. Applying these 
to neural cell types, with particular attention paid to comparing 
regeneration-competent and −incompetent states, will establish 
transcription factor regulatory networks that underlie axon growth. In 
turn, these networks can be targeted using strategies driven by the 
specifics of the identified interactions (tethered constructs, mutant 
forms, complementary epigenetic functions, etc.). Although applying 
this framework to neurons entails considerable effort, it promises rapid 
progress in clarifying and leveraging TF interactions for functional gain 
after CNS injury. 
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